Life ScienceCompany
G1 Therapeutics Ownership
Who owns G1 Therapeutics?
G1 Therapeutics is owned by Pharmacosmos A/S. It was acquired on August 7, 2024.
G1 Therapeutics Business Overview
Where is G1 Therapeutics headquartered?
G1 Therapeutics is headquartered in Research Triangle Park, North Carolina.
What is G1 Therapeutics’ revenue?
G1 Therapeutics disclosed revenue of 83M USD for 2023 and 51M USD for 2022.
What sector is G1 Therapeutics in?
G1 Therapeutics is a life science company.
Life Science M&A Summary in 2024
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.
Join Mergr to view all 195 acquisitions of life science companies in 2024, including 17 acquisitions by private equity firms, and 178 by strategics.